AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: 2940 nm Er:YAG laser followed by triamcinolone acetonide and 308 nm excimer laser (Group A)
Number of subjects: 21
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: 2940 nm Er:YAG laser followed by triamcinolone acetonide and 0.1% tacrolimus (Group B)
Number of subjects: 21
Study 36181292 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 21
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 21
Study 36181292 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 21
Study 33881408 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care professionals' attitudes toward older adults using technology (ATOAUT-10)
Number of subjects: 190
Study 33881408 — intervention group
Group type: COMPARATOR
Intervention: Old age salience manipulation in Study 2
Number of subjects: 190
Study 34424868 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpal tunnel release at various out-of-pocket price options ($250 to $3,000)
Number of subjects: 1408
Study 34424868 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation at various out-of-pocket price options ($250 to $3,000)
Number of subjects: 1408
Study 34424868 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-cutting measures (older-generation implants)
Number of subjects: 1408
Study 32763624 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic foot stiffness category
Number of subjects: 17
Study 32763624 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative foot stiffness perception
Number of subjects: 17
Study 35195344 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (exercise routines three times weekly and once weekly on discharge for 6 weeks supervised by a physical therapist)
Number of subjects: 40
Study 35195344 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 40
Study 33752768 — intervention group
Group type: EXPERIMENTAL
Intervention: Power (measured through scales assessing interpersonal power)
Number of subjects: 728
Study 33752768 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental manipulation of conflict's seriousness and power (in Studies 2-3)
Number of subjects: 728
Study 33752768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical regression analyses
Number of subjects: 728
Study 32348038 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing plates
Number of subjects: 18
Study 32348038 — intervention group
Group type: COMPARATOR
Intervention: iliosciatic plates fixation system
Number of subjects: 18
Study 32348038 — intervention group
Group type: COMPARATOR
Intervention: 2 parallel reconstruction plates fixation system
Number of subjects: 18
Study 34624497 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored chemotherapy (T), n = 384
Number of subjects: 773
Study 34624497 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy (C), n = 389
Number of subjects: 773
Study 34624497 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored chemotherapy (T)
Number of subjects: 773
Study 34624497 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy (C)
Number of subjects: 773
Study 36115360 — intervention group
Group type: EXPERIMENTAL
Intervention: CEA plus BMT
Number of subjects: 513
Study 36115360 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS plus BMT
Number of subjects: 513
Study 36115360 — intervention group
Group type: COMPARATOR
Intervention: BMT alone
Number of subjects: 513
Study 32966666 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser 2940 nm
Number of subjects: 20
Study 32966666 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser 980 nm
Number of subjects: 20
Study 32966666 — intervention group
Group type: COMPARATOR
Intervention: Both lasers
Number of subjects: 20
Study 36052889 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation (AO), motor imagery (MI), and gait training
Number of subjects: 39
Study 36052889 — intervention group
Group type: COMPARATOR
Intervention: Gait training
Number of subjects: 39
Study 33528779 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support intervention (values clarification exercise and CPR video decision aid)
Number of subjects: 200
Study 33528779 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 200
Study 33528779 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support intervention
Number of subjects: 200
Study 33934564 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo-guided optimization (EO)
Number of subjects: 27
Study 32729662 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG (epigallocatechin gallate)
Number of subjects: 90
Study 32729662 — intervention group
Group type: COMPARATOR
Intervention: Control (NC)
Number of subjects: 90
Study 32729662 — intervention group
Group type: COMPARATOR
Intervention: High-fat (HF)
Number of subjects: 90
Study 33407777 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic MSC (approximately 1 x 10^6 cells/kg)
Number of subjects: 20
Study 33407777 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution (same composition as the experimental treatment, without the MSC)
Number of subjects: 20
Study 33407777 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic MSC
Number of subjects: 20
Study 33407777 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 20
Study 34232082 — intervention group
Group type: COMPARATOR
Intervention: Yogurt smoothie (YS)
Number of subjects: 36
Study 34232082 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt smoothie with BB‐12 added prefermentation (PRE)
Number of subjects: 36
Study 34232082 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt smoothie with BB‐12 added postfermentation (POST)
Number of subjects: 36
Study 34232082 — intervention group
Group type: COMPARATOR
Intervention: Capsule containing BB‐12 (CAP)
Number of subjects: 36
Study 32449414 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth arm with digital data collection, vision screening test and retina evaluation using an integrated mobile application
Number of subjects: 2520
Study 32449414 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional arm with manual data collection and screening tests using Snellen chart and Fundus photography
Number of subjects: 2520
Study 32449414 — intervention group
Group type: COMPARATOR
Intervention: Control arm with manual data collection without screening tests
Number of subjects: 2520
Study 32449414 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth method
Number of subjects: 2520
Study 32449414 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional method
Number of subjects: 2520
Study 36205099 — intervention group
Group type: EXPERIMENTAL
Intervention: 50000 IU/day intramuscular vitamin A for a maximum of two weeks
Number of subjects: 30
Study 36205099 — intervention group
Group type: COMPARATOR
Intervention: Control group continued their common treatment protocols
Number of subjects: 30
Study 33496439 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping + combined chain exercises
Number of subjects: 60
Study 33496439 — intervention group
Group type: COMPARATOR
Intervention: Combined chain exercises
Number of subjects: 60
Study 32404430 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH pharmaco‐thromboprophylaxis and GCS
Number of subjects: 1905
Study 32404430 — intervention group
Group type: COMPARATOR
Intervention: LMWH pharmaco‐thromboprophylaxis alone
Number of subjects: 1905
Study 32404430 — intervention group
Group type: COMPARATOR
Intervention: LMWH alone
Number of subjects: 1905
Study 34633576 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipo‐MIT
Number of subjects: 60
Study 34633576 — intervention group
Group type: COMPARATOR
Intervention: MIT
Number of subjects: 60
Study 33760270 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-linguistic programming (NLP) for 30 min
Number of subjects: 0
Study 33760270 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery relaxation technique for 30 min
Number of subjects: 0
Study 33760270 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32241711 — intervention group
Group type: EXPERIMENTAL
Intervention: MyFood decision support system (app for patients and website for nurses)
Number of subjects: 100
Study 35588353 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician consultation
Number of subjects: 133
Study 35588353 — intervention group
Group type: COMPARATOR
Intervention: Control (audiologist follow-up only)
Number of subjects: 133
Study 33048456 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/Pibrentasvir (GLE/PIB) 300/120 mg
Number of subjects: 0
Study 33048456 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 0
Study 32957372 — intervention group
Group type: EXPERIMENTAL
Intervention: Farm work experience
Number of subjects: 600
Study 32957372 — intervention group
Group type: COMPARATOR
Intervention: No farm work experience
Number of subjects: 600
Study 32957372 — intervention group
Group type: EXPERIMENTAL
Intervention: Farm work experience (men)
Number of subjects: 600
Study 32957372 — intervention group
Group type: COMPARATOR
Intervention: No farm work experience (men)
Number of subjects: 600
Study 32957372 — intervention group
Group type: EXPERIMENTAL
Intervention: Farm work experience (women)
Number of subjects: 600
Study 32957372 — intervention group
Group type: COMPARATOR
Intervention: No farm work experience (women)
Number of subjects: 600
Study 32957372 — intervention group
Group type: EXPERIMENTAL
Intervention: Farm work experience (sensitivity analysis)
Number of subjects: 600
Study 32957372 — intervention group
Group type: COMPARATOR
Intervention: No farm work experience (sensitivity analysis)
Number of subjects: 600
Study 35907909 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior gastropexy
Number of subjects: 240
Study 35907909 — intervention group
Group type: COMPARATOR
Intervention: No anterior gastropexy (control)
Number of subjects: 240
Study 33448580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (target <120 mmHg)
Number of subjects: 9361
Study 33448580 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control (target <140 mmHg)
Number of subjects: 9361
Study 33448580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 9361
Study 32408396 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation-H
Number of subjects: 0
Study 32408396 — intervention group
Group type: COMPARATOR
Intervention: Methylation-M
Number of subjects: 0
Study 32408396 — intervention group
Group type: COMPARATOR
Intervention: Methylation-L
Number of subjects: 0
Study 32408396 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic signature based on six HPV-related methylation sites
Number of subjects: 0
Study 36064509 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus the text message support program
Number of subjects: 40
Study 36064509 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 40
Study 34672767 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (4.1 mmol NO3-/day; DNS)
Number of subjects: 11
Study 34990047 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 186
Study 34990047 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolic acid (MPA)
Number of subjects: 186
Study 33332454 — intervention group
Group type: EXPERIMENTAL
Intervention: EF-initiated PC-IRV (n = 14)
Number of subjects: 28
Study 33332454 — intervention group
Group type: COMPARATOR
Intervention: VCV (n = 14)
Number of subjects: 28
Study 36456987 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-coated locking plates
Number of subjects: 226
Study 36456987 — intervention group
Group type: COMPARATOR
Intervention: Uncoated locking plates
Number of subjects: 226
Study 34455822 — intervention group
Group type: EXPERIMENTAL
Intervention: Patent foramen ovale closure
Number of subjects: 560
Study 34455822 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 560
Study 36222880 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg dose of amiloride
Number of subjects: 10
Study 35437037 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Homestead Food Production (EHFP) program (2010-2012)
Number of subjects: 134
Study 35437037 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 134
Study 35074558 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary programming
Number of subjects: 2604
Study 35074558 — intervention group
Group type: EXPERIMENTAL
Intervention: Public works and complementary programming
Number of subjects: 2604
Study 35074558 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaging men in nutrition behaviour change communication
Number of subjects: 2604
Study 34591935 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical facemask
Number of subjects: 24
Study 34591935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloth facemask
Number of subjects: 24
Study 34591935 — intervention group
Group type: COMPARATOR
Intervention: No facemask
Number of subjects: 24
Study 36401234 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vitamin D3 (cholecalciferol) 800 IU and daily calcium citrate 600 mg
Number of subjects: 34
Study 36401234 — intervention group
Group type: COMPARATOR
Intervention: Only daily calcium citrate 600 mg
Number of subjects: 34
Study 33252102 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection and rNMES combined (group III)
Number of subjects: 64
Study 33252102 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection (group I)
Number of subjects: 64
Study 33252102 — intervention group
Group type: EXPERIMENTAL
Intervention: rNMES (group II)
Number of subjects: 64
Study 33252102 — intervention group
Group type: COMPARATOR
Intervention: Control (group IV)
Number of subjects: 64
Study 32241084 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with TPF (docetaxel & cisplatin 75 mg/m2 on D1, and fluorouracil 75 mg/m2 on D1-4) followed by CRT (cisplatin 100 mg/m2 on D1 3-weekly, two times plus radiotherapy 68.4 Gy/30 fractions)
Number of subjects: 36
Study 32241084 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CRT) alone (cisplatin 100 mg/m2 on D1 3-weekly, two times plus radiotherapy 68.4 Gy/30 fractions)
Number of subjects: 36
Study 32241084 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with TPF followed by CRT
Number of subjects: 36
Study 32241084 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CRT) alone
Number of subjects: 36
Study 33294725 — intervention group
Group type: EXPERIMENTAL
Intervention: B-EPIC intervention
Number of subjects: 100
Study 35733373 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (5000 IU daily for 4 months)
Number of subjects: 56
Study 35733373 — intervention group
Group type: COMPARATOR
Intervention: Placebo (topiramate with placebo capsule)
Number of subjects: 56
Study 33333466 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge insole (LWI) for 3 months in early OA group (n = 17)
Number of subjects: 39
Study 33333466 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention, n = 9)
Number of subjects: 39
Study 33333466 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge insole (LWI) for 3 months in late OA group (n = 13)
Number of subjects: 39
Study 35864545 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Labels (WL)
Number of subjects: 408
Study 35864545 — intervention group
Group type: COMPARATOR
Intervention: Nutrient Facts Panel (NF)
Number of subjects: 408
Study 35864545 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Warning Labels (WL)
Number of subjects: 408
Study 35864545 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeric Warning Labels (WL)
Number of subjects: 408
Study 35864545 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Labels with cartoon characters (WL + C)
Number of subjects: 408
Study 35864545 — intervention group
Group type: EXPERIMENTAL
Intervention: Video
Number of subjects: 408
Study 33991134 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 exposure at 1450 ppm (decreased ventilation)
Number of subjects: 15
Study 33991134 — intervention group
Group type: COMPARATOR
Intervention: CO2 exposure at 900 ppm (reference)
Number of subjects: 15
Study 33991134 — intervention group
Group type: COMPARATOR
Intervention: CO2 exposure at 1450 ppm (reference condition with added pure CO2)
Number of subjects: 15
Study 33003524 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 24
Study 33003524 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 24
Study 33003524 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT)
Number of subjects: 24
Study 33003524 — intervention group
Group type: COMPARATOR
Intervention: No calibration Dexcom G6 CGM
Number of subjects: 24
Study 35340223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride citrate tablets combined with ShenQu Xiaoshi oral liquid
Number of subjects: 136
Study 35340223 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group (Mosapride citrate tablets)
Number of subjects: 136
Study 33153827 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-processed foods (NOVA-4 foods) consumption in patients with AN
Number of subjects: 73
Study 33153827 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-processed foods (NOVA-4 foods) consumption in patients with BN
Number of subjects: 73
Study 33153827 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-processed foods (NOVA-4 foods) consumption in patients with BED
Number of subjects: 73
Study 33153827 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge eating episodes
Number of subjects: 73
Study 32931496 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual azithromycin distribution
Number of subjects: 27222
Study 32931496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27222
Study 34767705 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral-valve surgery plus tricuspid annuloplasty (TA)
Number of subjects: 401
Study 34767705 — intervention group
Group type: COMPARATOR
Intervention: Mitral-valve surgery alone
Number of subjects: 401
Study 34767705 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral-valve surgery plus TA
Number of subjects: 401
Study 34159294 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months adjuvant chemotherapy
Number of subjects: 160
Study 34159294 — intervention group
Group type: COMPARATOR
Intervention: 6 months adjuvant chemotherapy
Number of subjects: 160
Study 32238273 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNTAX Score II (SS-II) ≤ 23
Number of subjects: 723
Study 32238273 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNTAX Score II (23 < SS-II ≤ 31)
Number of subjects: 723
Study 32238273 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNTAX Score II (SS-II > 31)
Number of subjects: 723
Study 36183748 — intervention group
Group type: EXPERIMENTAL
Intervention: Edwards Magna bioprosthesis
Number of subjects: 300
Study 36183748 — intervention group
Group type: EXPERIMENTAL
Intervention: St.Jude Epic bioprosthesis
Number of subjects: 300
Study 36183748 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorin Mitroflow bioprosthesis
Number of subjects: 300
Study 36183748 — intervention group
Group type: COMPARATOR
Intervention: Control group (Magna)
Number of subjects: 300
Study 36183748 — intervention group
Group type: COMPARATOR
Intervention: Control group (Epic)
Number of subjects: 300
Study 33516531 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 1638
Study 33516531 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1638
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia (LA)
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Dry needling therapy
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Dry needling
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin-A (BTX-A)
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: Granisetron
Number of subjects: 959
Study 32159870 — intervention group
Group type: COMPARATOR
Intervention: PRP
Number of subjects: 959
Study 35220641 — intervention group
Group type: EXPERIMENTAL
Intervention: MflCas 2% topical treatment after 56 days
Number of subjects: 0
Study 32720415 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigenous food (IF) consumption
Number of subjects: 0
Study 32720415 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Accessed Diversity Index (FADI)
Number of subjects: 0
Study 32720415 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum dietary diversity score for women (MDD-W)
Number of subjects: 0
Study 32720415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment
Number of subjects: 0
Study 36067012 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin tests (STs) retest after initial evaluation (IE)
Number of subjects: 545
Study 33529256 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care
Number of subjects: 8843
Study 33529256 — intervention group
Group type: COMPARATOR
Intervention: Individual antenatal care (control)
Number of subjects: 8843
Study 33529256 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 8843
Study 33529256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 8843
Study 32489274 — intervention group
Group type: EXPERIMENTAL
Intervention: ibrutinib–rituximab
Number of subjects: 0
Study 32489274 — intervention group
Group type: EXPERIMENTAL
Intervention: acalabrutinib–obinutuzumab or acalabrutinib monotherapy
Number of subjects: 0
Study 32489274 — intervention group
Group type: EXPERIMENTAL
Intervention: zanubrutinib
Number of subjects: 0
Study 32489274 — intervention group
Group type: EXPERIMENTAL
Intervention: venetoclax–obinutuzumab
Number of subjects: 0
Study 35762237 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 exposure at 4000 ppm (Moderately High: MH)
Number of subjects: 12